We just look at where there’s a need and ask ourselves if we can do something.
World Renowned Surgeon / Inventor / Founder Crux Biomedical
Crux Biomedical, Inc. is a famous medical corporation, which creates and offers medical devices. Our main objective is to create dependable devices that protect people from pulmonary embolisms. The corporation was established in 2004 and since then, we continuously advance our technologies and methods of work to provide people with the most efficient and safe devices. Thus, we have created vena cava filters to prevent this dangerous disease.
Pulmonary embolism is a severe disease that blocks one of the arteries of the lungs. Commonly, it’s caused by blood clots. As they block the arteries, they threaten human life and so, this disease is taken seriously by our professional staff. We use a revolutionary device called a vena cava filter. Its main objective is to prevent the development of this life-threatening disease by trapping blood clots.
Our corporation creates, manufactures, and advances various vascular devices, which can be implanted. After the successful implantation, patients are not endangered by pulmonary embolism anymore. Crux Biomedical helps patients in every corner of the United States of America.
This severe disease is widely spread in the USA. Approximately 600,000 patients suffer from it and about 120,000 – 150,000 because of it. The development of the disease may be caused by other substances, but it’s a rarity. Our experts know that blood clots are the main source of its development. Therefore, all our knowledge, experience, and skills are targeted at the creation and improvement of special filters that successfully trap blood clots and thus, prevent the disease.
You can fully trust our creations. Our corporation and its devices are officially approved by the FDA. We have been awarded four important patents that prove our legal status. Consequently, the devices we have created are safe and effective to treat and prevent pulmonary embolism. Our filters are extremely easy to deploy. They are very effective and save human lives.
Another vital benefit of our filters is the possibility to retrieve them safely and quite easily. While some older models cause many difficulties for doctors and their patients, our filters can be retrieved with minimum risk for health. Thus, our filters are the 2-in-1 proposal. They treat pulmonary embolism and they can be successfully removed to ensure the safety of patients.